Ligand Pharmaceuticals Inc (LGND)

Investing Cash Flow

$321.12M

Quarterly · Period ending: · USD

LGND logo

LGND Investing Cash Flow

Latest reported$321.12M
LGND Quarterly Cash from Investing ($3.50M → $321.12M)
High-resolution chart · PNG

LGND investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
321,117,000
-94,347,000
-18,104,000
-353,445,000
-10,667,000
4,894,000
-38,623,000
-46,507,000
-54,759,000
-3,775,000
-10,284,000
-19,503,000
7,556,000
10,549,000
-7,284,000
19,176,000
37,851,000
113,881,000
-35,713,000
-18,217,000
19,338,000
65,115,000
-382,202,000
332,071,000
-26,757,000
308,536,000
-63,179,000
169,517,000
265,803,000
94,777,000
275,302,000
-78,252,000
-586,738,000
-33,581,000
-36,174,000
-56,538,000
39,201,000
-30,666,000
-86,727,000
5,078,000
18,217,000
-79,760,000
-11,477,000
-26,365,000
-72,223,000
-2,797,000
-1,711,000
72,000
610,000
-998,000
-1,003,000
-245,000
-3,692,000
-34,000
-72,000
-2,368,000
-242,000
3,945,000
-2,279,000
-137,000
453,000
-23,169,000
1,028,000
8,276,000
1,356,000
3,880,000
12,074,000
13,052,000
-4,231,000
3,873,000
10,960,000
-3,597,000
-26,010,000
-5,777,000
20,879,000
-9,649,000
6,323,000
326,284,000
199,746,000
-3,744,000
-2,132,000
2,995,000
5,120,000
11,055,000
-10,318,000
-39,575,000
22,839,000
8,854,000
-18,479,000
6,397,000
-27,767,000
3,071,000
3,471,000
-3,394,000
-102,277,000
-342,000
1,302,000
-3,928,000
4,280,000
-4,792,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.